Literature DB >> 27187092

A Randomized Trial on the Effect of Exercise Mode on Breast Cancer-Related Lymphedema.

Jena Buchan1, Monika Janda, Robyn Box, Kathryn Schmitz, Sandra Hayes.   

Abstract

PURPOSE: Breast cancer-related lymphedema is a common and debilitating side effect of cancer treatment. This randomized trial compared the effect of progressive resistance- or aerobic-based exercise on breast cancer-related lymphedema extent and severity, as well as participants' muscular strength and endurance, aerobic fitness, body composition, upper-body function, and quality of life.
METHODS: Women with a clinical diagnosis of stable unilateral, upper-limb lymphedema secondary to breast cancer were randomly allocated to a resistance-based (n = 21) or aerobic-based (n = 20) exercise group (12-wk intervention). Women were assessed preintervention, postintervention, and 12 wk postintervention, with generalized estimating equation models used to compare over time changes in each group's lymphedema (two-tailed P < 0.05).
RESULTS: Lymphedema remained stable in both groups (as measured by bioimpedance spectroscopy and circumferences), with no significant differences between groups noted in lymphedema status. There was a significant (P < 0.01) time-group effect for upper-body strength (assessed using four to six repetition maximum bench press), with the resistance-based exercise group increasing strength by 4.2 kg (95% confidence interval [CI] = 3.2-5.2) postintervention compared with 1.2 kg (95% CI = -0.1 to 2.5) in the aerobic-based exercise group. Although not supported statistically, the aerobic-based exercise group reported a clinically relevant decline in number of symptoms postintervention (-1.5, 95% CI = -2.6 to -0.3), and women in both exercise groups experienced clinically meaningful improvements in lower-body endurance, aerobic fitness, and quality of life by 12-wk follow-up. DISCUSSION: Participating in resistance- or aerobic-based exercise did not change lymphedema status but led to clinically relevant improvements in function and quality of life, with findings suggesting that neither mode is superior with respect to lymphedema effect. As such, personal preferences, survivorship concerns, and functional needs are important and relevant considerations when prescribing exercise mode to those with secondary lymphedema.

Entities:  

Mesh:

Year:  2016        PMID: 27187092     DOI: 10.1249/MSS.0000000000000988

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  15 in total

Review 1.  Rehabilitation interventions for the management of breast cancer-related lymphedema: developing a patient-centered, evidence-based plan of care throughout survivorship.

Authors:  Kathryn Ryans; Marisa Perdomo; Claire C Davies; Kimberly Levenhagen; Laura Gilchrist
Journal:  J Cancer Surviv       Date:  2021-01-22       Impact factor: 4.442

Review 2.  Resistance Exercise for Breast Cancer Patients? Evidence from the Last Decade.

Authors:  Lars Gerland; Freerk T Baumann; Timo Niels
Journal:  Breast Care (Basel)       Date:  2021-01-28       Impact factor: 2.860

3.  Effect of exercise mode on physical function and quality of life in breast cancer-related lymphedema: a randomized trial.

Authors:  Maged A Basha; Nancy H Aboelnour; Ashwag S Alsharidah; FatmaAlzahraa H Kamel
Journal:  Support Care Cancer       Date:  2021-10-20       Impact factor: 3.603

4.  Features, Predictors, and Treatment of Breast Cancer-related Lymphedema.

Authors:  Xiaochen Zhang; Jill M Oliveri; Electra D Paskett
Journal:  Curr Breast Cancer Rep       Date:  2020-09-09

5.  Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema.

Authors:  Shirin M Shallwani; Anna Towers; Anne Newman; Shannon Salvador; Angela Yung; Lucy Gilbert; Walter H Gotlieb; Xing Zeng; Doneal Thomas
Journal:  Curr Oncol       Date:  2021-01-13       Impact factor: 3.677

6.  Interventions for Breast Cancer-Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA.

Authors:  Claire Davies; Kimberly Levenhagen; Kathryn Ryans; Marisa Perdomo; Laura Gilchrist
Journal:  Phys Ther       Date:  2020-07-19

7.  Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.

Authors:  Michelle J Naughton; Heshan Liu; Drew K Seisler; Jennifer Le-Rademacher; Jane M Armer; Jill M Oliveri; Jeffrey A Sloan; Karen Hock; Michael Schwartz; Gary Unzeitig; Marianne Melnik; Lisa D Yee; Gini F Fleming; John R Taylor; Charles Loprinzi; Electra D Paskett
Journal:  Cancer       Date:  2020-10-20       Impact factor: 6.860

8.  A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance).

Authors:  Electra D Paskett; Jennifer Le-Rademacher; Jill M Oliveri; Heshan Liu; Drew K Seisler; Jeffrey A Sloan; Jane M Armer; Michelle J Naughton; Karen Hock; Michael Schwartz; Gary Unzeitig; Marianne Melnik; Lisa D Yee; Gini F Fleming; John R Taylor; Charles Loprinzi
Journal:  Cancer       Date:  2020-10-20       Impact factor: 6.860

Review 9.  Interventions for promoting habitual exercise in people living with and beyond cancer.

Authors:  Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke
Journal:  Cochrane Database Syst Rev       Date:  2018-09-19

10.  Resistance exercise and breast cancer-related lymphedema-a systematic review update and meta-analysis.

Authors:  Timothy Hasenoehrl; Stefano Palma; Dariga Ramazanova; Heinz Kölbl; Thomas E Dorner; Mohammad Keilani; Richard Crevenna
Journal:  Support Care Cancer       Date:  2020-05-15       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.